Qi Lunan, Xu Jingxuan, Chen Yuanyuan, Lu Zhan, Zhou Min, Huang Yingwu, Ling Yongchi, Huang Hai, Peng Yuchong, Peng Tao, Xiang Bangde, Ma Liang
Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning 530021, China.
Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning 530021, China.
Cancer Biol Med. 2025 Jul 11;22(8). doi: 10.20892/j.issn.2095-3941.2024.0514.
Hyper-progression recurrence (HPR) after hepatectomy is a specific recurrence pattern associated with extremely poor prognosis in patients with hepatocellular carcinoma (HCC). This study was aimed at investigating the probable risk factors and establishing comprehensive models for formulating clinical strategies.
Overall, 16,158 patients with HCC from 8 hospitals were screened, among whom 3,125 patients who underwent R0 resection were included, and divided into development ( = 2,113) and validation ( = 1,012) cohorts. A comprehensive study of HPR predictive models and biological features was conducted.
Among the 3,125 enrolled patients, 506 (16.19%) developed HPR. The influence of HPR on extremely poor prognosis was reflected by recurrence features, adverse effects on systemic and liver function, and limited therapeutic options. Nine variables closely associated with HPR were identified, and incorporated into nomogram and conditional inference tree models, which successfully achieved pre- and post-operative HPR risk stratification and facilitated clinical decision-making. Multi-dimensional verification also confirmed the predictive accuracy of model combinations and their reliability in clinical applications. Furthermore, biological analyses revealed that HCCs with HPR exhibited hyperactive biological processes, inactive metabolism, and immune exhaustion features, together with high MYCN/HMGA2 co-expression, thereby enhancing understanding of the molecular events leading to HPR and providing valuable knowledge for HPR management.
HPR after hepatectomy is associated with extremely poor prognosis and requires substantial attention. We constructed comprehensive predictive models and propose a clinical strategy for guiding HPR prevention and management.
肝切除术后的超进展复发(HPR)是肝细胞癌(HCC)患者中一种特定的复发模式,与极差的预后相关。本研究旨在调查可能的风险因素并建立综合模型以制定临床策略。
总体上,对来自8家医院的16158例HCC患者进行筛查,其中3125例接受了R0切除的患者被纳入研究,并分为开发队列(n = 2113)和验证队列(n = 1012)。对HPR预测模型和生物学特征进行了综合研究。
在3125例入组患者中,506例(16.19%)发生了HPR。HPR对极差预后的影响体现在复发特征、对全身和肝功能的不良影响以及有限的治疗选择上。确定了9个与HPR密切相关的变量,并将其纳入列线图和条件推断树模型,成功实现了术前和术后HPR风险分层并促进了临床决策。多维度验证也证实了模型组合的预测准确性及其在临床应用中的可靠性。此外,生物学分析显示,发生HPR的HCC表现出活跃的生物学过程、不活跃的代谢和免疫耗竭特征,同时伴有高MYCN/HMGA2共表达,从而加深了对导致HPR的分子事件的理解,并为HPR管理提供了有价值的知识。
肝切除术后的HPR与极差的预后相关,需要高度关注。我们构建了综合预测模型,并提出了一种指导HPR预防和管理的临床策略。